Update (06/12/2018): uniQure has incorporated Synpromics' strong liver promoter into a preclinical gene therapy candidate for treating hemophilia A. Published…
Synpromics, a Scottish-based synthetic biology company today announced that it has successfully generated several highly effective synthetic promoters for use…